A compound having Formula (I) or Formula (II)
is disclosed as an P2X
7
antagonist, wherein A, B, C, Y, Y, Z, m, v, R
1
, R
2
, R
3
, R
4
, and R
5
, are as defined in the description. Methods and compositions for treating disease or condition modulated by P2X
7
are also disclosed.
A compound having Formula (I) or Formula (II)
is disclosed as an P2X
7
antagonist, wherein A, B, C, Y, Y, Z, m, v, R
1
, R
2
, R
3
, R
4
, and R
5
, are as defined in the description. Methods and compositions for treating disease or condition modulated by P2X
7
are also disclosed.
A compound having Formula (I) or Formula (II)
is disclosed as an P2X
7
antagonist, wherein A, B, C, Y, Y, Z, m, v, R
1
, R
2
, R
3
, R
4
, and R
5
, are as defined in the description. Methods and compositions for treating disease or condition modulated by P2X
7
are also disclosed.